[go: up one dir, main page]

MX2018014922A - Metodos para detectar norovirus. - Google Patents

Metodos para detectar norovirus.

Info

Publication number
MX2018014922A
MX2018014922A MX2018014922A MX2018014922A MX2018014922A MX 2018014922 A MX2018014922 A MX 2018014922A MX 2018014922 A MX2018014922 A MX 2018014922A MX 2018014922 A MX2018014922 A MX 2018014922A MX 2018014922 A MX2018014922 A MX 2018014922A
Authority
MX
Mexico
Prior art keywords
methods
norovirus genogroup
gii
norovirus
detecting
Prior art date
Application number
MX2018014922A
Other languages
English (en)
Inventor
Tabb Michelle
Lee Peter
Chen Jules
Huang Raymond
Ramos Kristin
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2018014922A publication Critical patent/MX2018014922A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente descripción proporciona métodos y composiciones para determinar si un paciente que exhibe gastroenteritis aguda se beneficiará del tratamiento con agentes terapéuticos que inhiben al genogrupo I (GI) de Norovirus o genogrupo II (GII) de Norovirus. Los métodos descritos en la presente se basan en detectar al genogrupo I (GI) de Norovirus y genogrupo II (GIl) de Norovirus en una muestra de heces sin extraer ácidos nucleicos virales de un espécimen clínico antes de realizar PCR de transcripción inversa en tiempo real. También se proporcionan kits para su uso en la práctica de los métodos.
MX2018014922A 2016-06-03 2017-06-02 Metodos para detectar norovirus. MX2018014922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662345331P 2016-06-03 2016-06-03
PCT/US2017/035686 WO2017210558A1 (en) 2016-06-03 2017-06-02 Methods for detecting norovirus

Publications (1)

Publication Number Publication Date
MX2018014922A true MX2018014922A (es) 2019-08-29

Family

ID=60477891

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018014922A MX2018014922A (es) 2016-06-03 2017-06-02 Metodos para detectar norovirus.
MX2022014633A MX2022014633A (es) 2016-06-03 2018-11-30 Metodos para detectar norovirus.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022014633A MX2022014633A (es) 2016-06-03 2018-11-30 Metodos para detectar norovirus.

Country Status (7)

Country Link
US (3) US10793924B2 (es)
EP (1) EP3464647A4 (es)
CN (1) CN110073005A (es)
BR (1) BR112018074853A2 (es)
CA (1) CA3025675A1 (es)
MX (2) MX2018014922A (es)
WO (1) WO2017210558A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019212023A1 (ja) * 2018-05-02 2019-11-07 タカラバイオ株式会社 Ｒｎａウイルスの処理方法
CN109265542B (zh) * 2018-09-27 2021-06-15 国药中生生物技术研究院有限公司 特异性结合诺如病毒gii.4基因型vp1蛋白或vlp的抗体及其制备方法和应用
CN110343783B (zh) * 2019-07-08 2020-04-28 广东省公共卫生研究院 基于高通量测序的诺如病毒测序引物、试剂盒及检测方法
CN110592284A (zh) * 2019-10-12 2019-12-20 福建谷科生物科技有限公司 一种快速检测诺如病毒的试剂盒
CN110791589A (zh) * 2019-10-18 2020-02-14 张家口健垣科技有限公司 一种用于rna恒温扩增检测诺如病毒的引物和探针、试剂盒及检测方法
CN111019908B (zh) * 2019-12-13 2022-10-14 广东省微生物研究所（广东省微生物分析检测中心） 一种从牡蛎中高效提取诺如病毒的样本高通量前处理方法及试剂盒
CN111187861B (zh) * 2020-02-26 2023-05-23 中国热带农业科学院热带生物技术研究所 一种对海产品诺如病毒gii.4的检测方法
WO2022165220A1 (en) * 2021-01-29 2022-08-04 Kansas State University Research Foundation Conformationally-constrained inhibitors of 3c or 3c-like proteases
CN112725543B (zh) * 2021-03-04 2022-05-10 广东省科学院微生物研究所(广东省微生物分析检测中心) 人源诺如病毒gii.4型的特征性核酸鉴别引物组、试剂盒和检测方法
CN113025758A (zh) * 2021-04-07 2021-06-25 拱北海关技术中心 用于检测水产品gi型诺如病毒的引物、探针及试剂盒
CN114317814B (zh) * 2021-08-12 2024-06-14 中国科学院微生物研究所 用于检测临床样本中gi.7型诺如病毒的试剂盒及专用引物
CN116042928B (zh) * 2023-02-22 2024-01-02 中国人民解放军军事科学院军事医学研究院 用于扩增和检测消化道病毒核酸序列的引物组

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135717A (en) 1986-12-24 1992-08-04 British Technology Group Usa Inc. Tetrabenztriazaporphyrin reagents and kits containing the same
US5652099A (en) 1992-02-12 1997-07-29 Conrad; Michael J. Probes comprising fluorescent nucleosides and uses thereof
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US7202032B2 (en) * 2000-09-29 2007-04-10 Bml, Inc. Method of detecting Norwalk-like virus (GI)
US6630300B2 (en) * 2000-11-21 2003-10-07 Tosoh Corporation Oligonucleotides and method for characterizing and detecting Genogroup II type small round structured virus
US20060110724A1 (en) 2004-11-19 2006-05-25 Burkhardt William Iii Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard
EP3382011A1 (en) * 2008-08-08 2018-10-03 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
WO2013006793A2 (en) * 2011-07-06 2013-01-10 Quest Diagnostics Investments Incorporated Direct amplification and detection of viral and bacterial pathogens
CN103131798A (zh) * 2013-02-25 2013-06-05 湖北朗德医疗科技有限公司 一种诺如病毒实时荧光rt-pcr检测试剂盒及其应用
CN107250377B (zh) * 2014-11-25 2022-04-29 奎斯特诊断投资股份有限公司 生物样品中的核酸的扩增和检测
CN105177185A (zh) * 2015-10-10 2015-12-23 山东出入境检验检疫局检验检疫技术中心 果蔬中甲型肝炎病毒和诺如病毒检测质控试剂盒和检测方法

Also Published As

Publication number Publication date
CN110073005A (zh) 2019-07-30
US20190211408A1 (en) 2019-07-11
US20230279513A1 (en) 2023-09-07
US11555223B2 (en) 2023-01-17
EP3464647A1 (en) 2019-04-10
US20210095352A1 (en) 2021-04-01
US10793924B2 (en) 2020-10-06
WO2017210558A1 (en) 2017-12-07
MX2022014633A (es) 2023-01-11
EP3464647A4 (en) 2020-01-01
CA3025675A1 (en) 2017-12-07
BR112018074853A2 (pt) 2019-04-02
US12077830B2 (en) 2024-09-03

Similar Documents

Publication Publication Date Title
MX2022014633A (es) Metodos para detectar norovirus.
EA201790716A1 (ru) Использование панелей мутантных генов fgfr для выявления онкологических пациентов, которые будут поддаваться лечению ингибитором fgfr
AR119878A2 (es) Composiciones y métodos para detectar un contaminante biológico
CL2017003069A1 (es) Métodos para diagnosticar y tratar el cáncer.
WO2015128272A3 (en) Photo-selective method for biological sample analysis field
EP4556576A3 (en) Methods to diagnose and treat acute respiratory infections
EP3983543A4 (en) REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS
SG10201901076WA (en) Methods of treating alzheimer's disease
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
WO2016013940A3 (en) Novel test for microbial blood infections
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
WO2015092046A3 (en) Prostate cancer biomarkers
BR112014026440A2 (pt) assays, methods and apparatus for assessing rna disruption
MX2018000528A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
EP4591867A3 (en) Methods for detecting bordetella
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.
EP4407047A3 (en) Molecular detection of enterovirus and parechovirus
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
MX2021009281A (es) Metodos de deteccion de legionella.
WO2015013455A3 (en) Methods and compositions for the treatment and diagnosis of cancer
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
WO2015091902A3 (en) Determination of platelet-mirnas in alzheimer's disease
WO2015187953A8 (en) Method for direct microbial identification
BR112016006772A2 (pt) Métodos para determinar a qualidade de um suco ou cidra, se a quantidade de um microrganismo em um suco ou cidra é muito alta, se um suco ou cidra é inseguro para consumo e uma qualidade do gosto de uma amostra de suco e método melhorado para isolar ácidos nucleicos de um líquido